The last decade has seen entheogenic compounds move from the cultural fringe back into serious clinical research. Trials at Johns Hopkins, NYU, Imperial College London, and UCSF have looked at psilocybin and related compounds for treatment-resistant depression, end-of-life anxiety, post-traumatic stress, alcohol and tobacco use disorder, cluster headaches, and obsessive compulsive presentations. Many of these results have been striking enough to earn FDA Breakthrough Therapy designations.
We are not a clinic and we don't make treatment claims. What we do do is build the cleanest, most consistent, most transparently-tested products we can — so people who choose to explore can do so with the safety floor that pharmaceutical-grade quality control provides. The science is finally catching up to what cultures around the world have known for thousands of years: these are powerful tools, and powerful tools deserve precision.
Important. ShroomHaven products are not intended to diagnose, treat, cure, or prevent any disease. We are not a substitute for licensed medical care. If you take prescription medication (especially SSRIs, MAOIs, lithium, or tramadol), are pregnant or nursing, or have a personal or family history of psychotic spectrum conditions, talk to a clinician before using entheogenic products.